BioSpace News Archive

Tango Therapeutics, Inc. today announced that five abstracts have been selected for poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place from October 11-15, 2023 in Boston, Massachusetts.

Acepodia today announced that Nobel Laureate Carolyn Bertozzi, Ph.D., was recently appointed Chief Scientific Advisor.

Factorial Biotechnologies and Ginkgo Bioworks today announced a new collaboration.

Osmol Therapeutics today announced that the U.S. Food and Drug Administration (FDA) notified the company that the first-in-human clinical trial of OSM-020.

FSD Pharma Inc. today announced that an interim report has been received for the first-in-human single ascending dose Phase I clinical trial evaluating the Company’s novel drug candidate Lucid-21-302 (“Lucid-MS”), an orally-administered treatment for Multiple Sclerosis (“MS”).

Aptose Biosciences Inc. today announced that the Aptose management team will participate in the Cantor Global Healthcare Conference being held September 26-28, 2023, in New York City.

Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard) announces today that it has selected its lead candidate for MDG2011, a T cell receptor engineered T cell (TCR-T) therapy targeting KRAS (Kirsten rat sarcoma viral oncogene homologue) G12V with HLA-A*11 and being developed in combination with the Company’s PD1-41BB costimulatory switch protein (CSP) technology.

Alpha Teknova, Inc. announced that it has entered into definitive agreements for the issuance and sale of an aggregate of up to 1,086,485 of its shares of common stock in a registered direct offering at a purchase price of $1.85 per share.

POINT Biopharma Global Inc. and Athebio AG announced a collaboration and license agreement to develop and commercialize DARPin-targeted radioligands.

HKG Epitherapeutics announced that its CEO, Prof. Moshe Szyf, delivered a keynote presentation at BIOHK2023 titled, “DNA methylation in health and disease; implications for early prediction, prevention and intervention.” The event took place in Hong Kong, China on September 13-16, 2023.